Gene · 51115
Papers3,244
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,244
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural products against tau hyperphosphorylation-induced aggregates: Potential therapies for Alzheimer's disease. | Arch Pharm (Weinheim) | 2025 | 39888017 | PubTator, text mining | PubMed |
| Arginylation of ⍺-tubulin at E77 regulates microtubule dynamics via MAP1S. | J Cell Biol | 2025 | 39852692 | PubTator, text mining | PubMed |
| Nuclear Tau accumulation in Alzheimer's disease. | Adv Protein Chem Struct Biol | 2025 | 39843139 | PubTator, text mining | PubMed |
| Non-mutated human tau stimulates Alzheimer's disease-relevant neurodegeneration in a microglia-dependent manner. | bioRxiv | 2025 | 39829837 | PubTator, text mining | PubMed |
| Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers. | ACS Chem Neurosci | 2025 | 39714208 | PubTator, text mining | PubMed |
| Microglia internalize tau monomers and fibrils using distinct receptors but similar mechanisms. | Alzheimers Dement | 2025 | 39713861 | PubTator, text mining | PubMed |
| LC3B: A microtubule-associated protein influences disease progression and prognosis. | Cytokine Growth Factor Rev | 2025 | 39701849 | PubTator, text mining | PubMed |
| Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases. | Chembiochem | 2025 | 39688878 | PubTator, text mining | PubMed |
| Targeting tau in Alzheimer's and beyond: Insights into pathology and therapeutic strategies. | Ageing Res Rev | 2025 | 39674375 | PubTator, text mining | PubMed |
| The emerging roles of particulate matter-changed non-coding RNAs in the pathogenesis of Alzheimer's disease: A comprehensive in silico analysis and review. | Environ Pollut | 2025 | 39631655 | PubTator, text mining | PubMed |
| Reprogramming metabolic microenvironment for nerve regeneration via waterborne polylactic acid-polyurethane copolymer scaffolds. | Biomaterials | 2025 | 39515191 | PubTator, text mining | PubMed |
| Mendelian Randomization Estimates the Effects of Plasma and Cerebrospinal Fluid Proteins on Intelligence, Fluid Intelligence Score, and Cognitive Performance. | Mol Neurobiol | 2025 | 39495227 | PubTator, text mining | PubMed |
| Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease. | Neural Regen Res | 2025 | 39104096 | PubTator, text mining | PubMed |
| Acetylation mimetic and null mutations within the filament core of P301L tau have varied effects on susceptibility to seeding and aggregation. | bioRxiv | 2025 | 38659970 | PubTator, text mining | PubMed |
| Amyloid-motif-dependent tau self-assembly is modulated by isoform sequence context. | bioRxiv | 2025 | 38168322 | PubTator, text mining | PubMed |
| Emerging role of antioxidants in Alzheimer's disease: Insight into physiological, pathological mechanisms and management. | Pharm Sci Adv | 2024 | 41550171 | PubTator, text mining | PubMed |
| Promising Biomarkers for Spinal Cord Injury: A Brief Review. | Curr Trends Biomed Eng Biosci | 2024 | 40894309 | PubTator, text mining | PubMed |
| Involvement of RBP-J interacting and tubulin-associated protein in the distribution of protein regulator of cytokinesis 1 in mitotic spindles. | Front Cell Dev Biol | 2024 | 39839673 | PubTator, text mining | PubMed |
| Cold Inducible RNA-Binding Protein Promotes the Development of Alzheimer's Disease Partly by Inhibition of uPA in Astrocytes. | Degener Neurol Neuromuscul Dis | 2024 | 39741909 | PubTator, text mining | PubMed |
| Doublecortin regulates the mitochondrial-dependent apoptosis in glioma via Rho-A/Net-1/p38-MAPK signaling. | Mol Med | 2024 | 39719558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51115/papers?page=7